FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 48 filers reported holding FINCH THERAPEUTICS GROUP INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $793 | +62.2% | 2,019,008 | +98.1% | 0.01% | +75.0% |
Q4 2022 | $489 | -100.0% | 1,019,008 | -9.3% | 0.01% | -75.0% |
Q3 2022 | $1,876,000 | -41.2% | 1,123,108 | 0.0% | 0.03% | -31.9% |
Q2 2022 | $3,190,000 | -43.5% | 1,123,108 | 0.0% | 0.05% | -23.0% |
Q1 2022 | $5,649,000 | -50.0% | 1,123,108 | -0.8% | 0.06% | -45.0% |
Q4 2021 | $11,289,000 | -28.1% | 1,132,253 | -6.3% | 0.11% | -22.9% |
Q3 2021 | $15,706,000 | -5.9% | 1,208,159 | 0.0% | 0.14% | +6.7% |
Q2 2021 | $16,693,000 | -11.5% | 1,208,159 | 0.0% | 0.14% | -10.0% |
Q1 2021 | $18,870,000 | – | 1,208,159 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|